✦ LIBER ✦

Expenditure and effectiveness of treatment options in chronic myeloid leukemia patients who failed in the first-line imatinib treatment

✍ Scribed by Chen, W.; Zhu, J.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN2 COST-EFFECTIVENESS OF IMATINIB (GLE

✍ K El Ouagari; W Talbot; JF Baladi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Dasatinib in the first-line treatment of

✍ Patricia Ault 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 264 KB

PCN60 Cost Effectiveness of Nilotinib, D

✍ Romero Martin, R.M.; Alvis Nelson, A.N.; De los Ríos Magalí, D.L.R.M.; Chávez Di 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Six-year follow-up of patients receiving

✍ Hochhaus, A; O'Brien, S G; Guilhot, F; Druker, B J; Branford, S; Foroni, L; Gold 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 55 KB

Six-year follow-up of patients receiving

✍ Hochhaus, A; O'Brien, S G; Guilhot, F; Druker, B J; Branford, S; Foroni, L; Gold 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 608 KB

Dasatinib and nilotinib in first-line tr

✍ Jame Abraham 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 77 KB